BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19376844)

  • 1. Statins in COPD: a systematic review.
    Janda S; Park K; FitzGerald JM; Etminan M; Swiston J
    Chest; 2009 Sep; 136(3):734-743. PubMed ID: 19376844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between statins and COPD: a systematic review.
    Dobler CC; Wong KK; Marks GB
    BMC Pulm Med; 2009 Jul; 9():32. PubMed ID: 19594891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin Effects on Exacerbation Rates, Mortality, and Inflammatory Markers in Patients with Chronic Obstructive Pulmonary Disease: A Review of Prospective Studies.
    Howard ML; Vincent AH
    Pharmacotherapy; 2016 May; 36(5):536-47. PubMed ID: 26990316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational research.
    Cao C; Wu Y; Xu Z; Lv D; Zhang C; Lai T; Li W; Shen H
    Sci Rep; 2015 Nov; 5():16461. PubMed ID: 26553965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Studies of Statins in Asthma and COPD.
    Thomson NC
    Curr Mol Pharmacol; 2017; 10(1):60-71. PubMed ID: 26758945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Statins on COPD: A Meta-Analysis of Randomized Controlled Trials.
    Zhang W; Zhang Y; Li CW; Jones P; Wang C; Fan Y
    Chest; 2017 Dec; 152(6):1159-1168. PubMed ID: 28847550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
    Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities.
    Young RP; Hopkins RJ
    Expert Rev Respir Med; 2013 Oct; 7(5):533-44. PubMed ID: 24138695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan.
    Ishida W; Kajiwara T; Ishii M; Fujiwara F; Taneichi H; Takebe N; Takahashi K; Kaneko Y; Segawa I; Inoue H; Satoh J
    Tohoku J Exp Med; 2007 Jul; 212(3):265-73. PubMed ID: 17592214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink.
    Smith MC; Ashdown HF; Sheppard JP; Butler CC; Bankhead C
    BMJ Open; 2021 Dec; 11(12):e050757. PubMed ID: 34876426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan.
    Huang CC; Chan WL; Chen YC; Chen TJ; Chou KT; Lin SJ; Chen JW; Leu HB
    Clin Ther; 2011 Oct; 33(10):1365-70. PubMed ID: 21962452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study.
    Blamoun AI; Batty GN; DeBari VA; Rashid AO; Sheikh M; Khan MA
    Int J Clin Pract; 2008 Sep; 62(9):1373-8. PubMed ID: 18422598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin use and risk of COPD exacerbation requiring hospitalization.
    Wang MT; Lo YW; Tsai CL; Chang LC; Malone DC; Chu CL; Liou JT
    Am J Med; 2013 Jul; 126(7):598-606.e2. PubMed ID: 23684060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Statins and COPD: relationship with inflammation, exacerbations and mortality].
    Damkjær M; Håkansson KEJ; Ulrik CS; Godtfredsen NS
    Ugeskr Laeger; 2020 Jun; 182(23):. PubMed ID: 32515342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use and exacerbations in individuals with chronic obstructive pulmonary disease.
    Ingebrigtsen TS; Marott JL; Nordestgaard BG; Lange P; Hallas J; Vestbo J
    Thorax; 2015 Jan; 70(1):33-40. PubMed ID: 25349333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stats are in: an update on statin use in COPD.
    Carlson AA; Smith EA; Reid DJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2277-84. PubMed ID: 26543360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use is associated with reduced mortality in COPD.
    Søyseth V; Brekke PH; Smith P; Omland T
    Eur Respir J; 2007 Feb; 29(2):279-83. PubMed ID: 17050558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and Mortality in COPD: A Methodological Review of Observational Studies.
    Sule NO; Suissa S
    COPD; 2023 Dec; 20(1):284-291. PubMed ID: 37555454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study.
    Raymakers A; Sin DD; Sadatsafavi M; FitzGerald JM; Marra CA; Lynd LD
    Respir Res; 2020 May; 21(1):118. PubMed ID: 32429927
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.